Exploration in the Mechanism of Kaempferol for the Treatment of Gastric Cancer Based on Network Pharmacology

Table 4

Immunohistochemistry analysis of the ESR1, EGFR, and SRC in GC and normal tissues.

Gene	Patient ID	Type	Age	Sex	Intensity	Quantity	Location
ESR1	328	Normal tissue	75	Female	Negative	None	None
	2626	Adenocarcinoma	79	Female	Negative	None	None
EGFR	2411	Normal tissue	71	Female	Negative	None	None
	664	Adenocarcinoma	50	Female	Strong	>75%	Cytoplasmic/membranous
SRC	2130	Normal tissue	56	Female	Weak	75%-25%	Cytoplasmic/membranous
	2378	Adenocarcinoma	59	Male	Strong	>75%	Cytoplasmic/membranous